Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Clinical trial NCT06068868 · TERMINATED
Trial details
- NCT number
- NCT06068868
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2025-02-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.